Literature DB >> 16874842

Fetal abnormalities leading to termination of singleton pregnancy: the 7-year experience of a single medical center.

Zvi Vaknin1, Ido Ben-Ami, Orit Reish, Arie Herman, Ron Maymon.   

Abstract

OBJECTIVE: To assess the distribution of fetal indications leading to termination of pregnancy (TOP) in our institute.
METHODS: All pregnant women with singleton pregnancies who underwent TOP due to fetal abnormalities in our institute between January, 1998 and December, 2004 were divided between early TOP (<23 weeks' gestation) and late TOP (> or =23 weeks' gestation).
RESULTS: There were 328 (71%) and 134 (29%) early and late TOPs, respectively. The TOPs were performed at a mean gestational age of 20.1 +/- 4.8 weeks. The groups varied significantly in the indications for TOP (p = 0.04), which were primarily structural abnormalities (mostly CNS) followed by chromosomal/genetic defects. Fetal structural abnormalities were more common in the late TOP group (62.7% vs 54.2%) while chromosomal-genetic defects were more common in the early TOP group (40% vs 29.1%, respectively). Fetal infection (mostly cytomegalovirus) was similar ( approximately 4%) for both groups. The early TOP group had significantly more hydrops, gastrointestinal, face and neck abnormalities, while the late TOP group had significantly more cardiovascular abnormalities (p < 0.01).
CONCLUSIONS: The impact of early chromosomal/genetic screening contributes to early TOPs, while midgestation anomaly and cardiac scanning significantly contribute to late TOPs. Fetal infection contributes equally to both categories of TOPs.

Entities:  

Mesh:

Year:  2006        PMID: 16874842     DOI: 10.1002/pd.1531

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Termination of pregnancy and reasons for delayed decisions.

Authors:  Ali Gedikbaşı; Ahmet Gül; Kazım Oztarhan; Mustafa Ali Akın; Akif Sargın; Sibel Ozek; Sultan Kavuncuoğlu; Yavuz Ceylan
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-03-01

2.  Genetic counseling for fetal abnormalities in a South African community.

Authors:  Caryn Todd; Tabitha Haw; Jennifer Kromberg; Arnold Christianson
Journal:  J Genet Couns       Date:  2010-02-05       Impact factor: 2.537

3.  Prenatal diagnosis of skeletal dysplasia due to FGFR3 gene mutations: a 9-year experience : prenatal diagnosis in FGFR3 gene.

Authors:  M J Trujillo-Tiebas; M Fenollar-Cortés; I Lorda-Sánchez; J Díaz-Recasens; A Carrillo Redondo; C Ramos-Corrales; C Ayuso
Journal:  J Assist Reprod Genet       Date:  2009-09-30       Impact factor: 3.412

4.  Central nervous system congenital malformations in a developing country: issues and challenges against their prevention.

Authors:  Amos Olufemi Adeleye; Magbagbeola D Dairo; Kayode G Olowookere
Journal:  Childs Nerv Syst       Date:  2010-01-21       Impact factor: 1.475

5.  Trends in fetal indications for termination of pregnancy between 2002 and 2010 at a tertiary referral centre.

Authors:  Aytül Corbacıoğlu; Halil Aslan; Serdar Aydın; Ozgür Akbayır; Fırat Ersan; Verda Alpay; Hediye Dağdeviren; Songül Kısacık
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-06-01

6.  Accuracy of prenatal diagnosis in elective termination of pregnancy: 385 cases from 2000 to 2007.

Authors:  Fabiana Ramos; Sofia Maia; Miguel Branco; Joana Raposo; Joaquim Sá; Sérgio Sousa; Margarida Venâncio; Raquel Pina; Eulália Galhano; Lina Ramos; Jorge Saraiva
Journal:  ISRN Obstet Gynecol       Date:  2010-11-08

7.  [Confrontation between ultrasound and fetopathological examination following therapeutic abortion performed in a maternity clinic in Tunisia].

Authors:  Mehdi Kehila; Ahmed Halouani; Omar Touhami; Hassine Saber Abouda; Abdeljalil Khlifi; Rim Ben Hmid; Ines Benhassen; Aida Masmoudi; Mohamed Badis Chanoufi
Journal:  Pan Afr Med J       Date:  2016-12-21

8.  Retrospective clinical evaluation of indications for termination of pregnancies due to fetal anomaly

Authors:  Özlem Koşar Can; Babür Kaleli
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.